Adms stock history

Stock quote for Adamas Pharmaceuticals, Inc. Common Stock Common Stock (ADMS) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. ADMS | Adamas Pharmaceuticals Inc. Historical Quotes ...

ADMS Dividend History & Description — Adamas Pharmaceuticals Inc. Adamas Pharmaceuticals focuses on time-dependent medicines to enhance the daily living experience of those affected by entral nervous system disorders. Adamas Pharmaceuticals, Inc. - ADMS - Stock Price Today ... View Adamas Pharmaceuticals, Inc. ADMS investment & stock information. Get the latest Adamas Pharmaceuticals, Inc. ADMS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Adamas Pharmaceuticals, Inc. (ADMS) Historical Prices ... Historical Prices for Adamas Pharmaceuticals, Inc. (ADMS). Adamas Pharmaceuticals Market Cap 2013-2019 | ADMS ... Adamas Pharmaceuticals market cap history and chart from 2013 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

View the latest Adamas Pharmaceuticals Inc. (ADMS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Mar 26, 2020 · ADMS has not been significantly increasing the number of shares outstanding within recent years which is a good sign. ADMS currently has 21.0 million shares outstanding. This means the company is not taking any measures, with regards to the number of shares, that will dilute or devalue the stock. SALES: [PASS] Adamas Pharmaceuticals (ADMS) Stock Price History ... Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple ADMS Stock News - Fidelity Apr 01, 2020 · Adamas Pharmaceuticals, Inc. (ADMS) today announced that the compensation committee of the company s board of directors granted four new employees the option to purchase an aggregate of 89,000 shares of the company s common stock, at a per share exercise price of $6.48, the closing trading price on December 6, and restricted stock units to ADMS Market Cap History

Press Releases · Events & Presentations · Stock Information · Analyst various segments with a demonstrated history of success; Ability to positively position a 

Mar 26, 2020 · ADMS has not been significantly increasing the number of shares outstanding within recent years which is a good sign. ADMS currently has 21.0 million shares outstanding. This means the company is not taking any measures, with regards to the number of shares, that will dilute or devalue the stock. SALES: [PASS] Adamas Pharmaceuticals (ADMS) Stock Price History ... Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple ADMS Stock News - Fidelity Apr 01, 2020 · Adamas Pharmaceuticals, Inc. (ADMS) today announced that the compensation committee of the company s board of directors granted four new employees the option to purchase an aggregate of 89,000 shares of the company s common stock, at a per share exercise price of $6.48, the closing trading price on December 6, and restricted stock units to ADMS Market Cap History ADMS Stock Price Chart: Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ADMS market cap history over the course of time is important for investors interested in comparing ADMS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock

Adamas Pharmaceuticals, Inc. (ADMS) Stock Analysis & News ...

ADMS - Adamas Pharmaceuticals Summary, Stock ... - Benzinga

Adamas Pharmaceuticals, Inc. (ADMS) Stock Price, Quote ...

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple ADMS Stock News - Fidelity

View the latest ADMS stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ADAMAS PHARMACEUTICALS, INC.. Adamas Pharmaceuticals Inc. Stock Price (ADMS) | Barron's Mar 24, 2020 · View today's stock price, news and analysis for Adamas Pharmaceuticals Inc. (ADMS). Barron's also provides information on historical stock ratings, target prices, company earnings, market